SPARC — Sun Pharma Advanced Research Co Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹68.07bn
- IN₹73.64bn
- IN₹18.79bn
Annual cashflow statement for Sun Pharma Advanced Research Co, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2,034 | -2,226 | -3,868 | -3,428 | 15,530 |
| Depreciation | |||||
| Non-Cash Items | 65.1 | -47.8 | -234 | 81.3 | 310 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -215 | 1,465 | -314 | -380 | -18,329 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2,082 | -691 | -4,292 | -3,603 | -2,388 |
| Capital Expenditures | -327 | -154 | -265 | -103 | -238 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 35.1 | -5,329 | 4,180 | 1,680 | 3.3 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -292 | -5,483 | 3,915 | 1,577 | -235 |
| Financing Cash Flow Items | -223 | -77.2 | -16 | -84.2 | -342 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2,293 | 6,168 | 424 | 1,993 | 2,614 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -80.8 | -6.41 | 47.5 | -33.7 | -8 |